Priorix (measles, mumps, and rubella vaccine, live) – New vaccine approval
June 6, 2022 - GSK announced the FDA approval of Priorix (measles, mumps, and rubella vaccine, live), for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.
Download PDF
